Cross-Sector entity
Of the tracked stories, 2 of 4 also mention Ebola outbreak (DRC), the most common co-covered peer. The 26-day window averages about 1.1 stories each week. The busiest single day carried 2. Coverage clusters in clinical-trial, which accounts for 1 of those 4, with the remainder spread across 3 other categories.
4 verified stories tracked
Last mentioned: 3d ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 4 also mention Ebola outbreak (DRC), the most common co-covered peer. The 26-day window averages about 1.1 stories each week. The busiest single day carried 2. Coverage clusters in clinical-trial, which accounts for 1 of those 4, with the remainder spread across 3 other categories. Each carries 2 original sources on average. We currently track 4 Cross-Sector stories that mention Democratic Republic of Congo, published between July 27, 2026 and August 21, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Democratic Republic of Congo. Shared-story counts are live from our verified record — not editorial picks.
3,000 Cases Milestone
Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.
First Experimental Vaccine Volunteer Dosed
Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.
2,000 Cases Surpassed
Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.
Outbreak Declared
DR Congo announces its 17th Ebola outbreak, identifying the Bundibugyo strain as the cause.
DR Congo's Ebola outbreak is expanding exponentially with 5,290 cases and a 47.6% fatality rate. Healthcare workers face extreme infection and attack risks while funding runs out, exposing critical gaps in health system capacity, surveillance, and emergency response.
The deadliest Ebola outbreak in DR Congo history has reached 5,290 cases and 2,516 deaths, with a 47.6% case fatality rate. For biotech and pharma, the accelerating spread highlights urgent demand for vaccines, therapeutics, and rapid diagnostics in conflict settings.
Source: globalissues.org · aa.com.tr
The WHO director-general warns that Ebola cases in DRC are doubling weekly in hotspots, reaching 3,874 confirmed cases and 1,751 deaths. The US has committed over $500 million to the response, but health system and security gaps remain critical. Urgent investments in surveillance, health worker support, and community access are needed.
Source: freemalaysiatoday.com · bangkokpost.com
DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.
Source: english.aawsat.com · manilatimes.net
